title: Pulmonary hypertension: chapters of innovation and tribulation.
abstract: As can be seen by the mounting literature, there has been immense progress in the field of pulmonary hypertension (PH) over the last three decades, illustrated by several important milestones including improved understanding of disease pathogenesis, new classifications of disease, advances in screening and diagnostic techniques, and new rules for staging and follow-up, which have subsequently led to improvements in patient outcomes. The objectives of this manuscript are to not only highlight these very recent advances but also point out areas of deficiencies or gaps in our knowledge that may serve a focal point for future discussion and investigation.
authors.affiliation: Division of Cardiology, Department of Internal Medicine II, Vienna General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. irene.lang@meduniwien.ac.at
authors.forename: Irene M
authors.initials: IM
authors.lastname: Lang
authors.forename: Raymond
authors.initials: R
authors.lastname: Benza
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D055808:Drug Discovery; D042241:Early Diagnosis; D006801:Humans; D006976:Hypertension, Pulmonary / Q000235:genetics / Q000401:mortality / Q000628:therapy*; D053208:Kaplan-Meier Estimate; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment
chemical_list: D000959:Antihypertensive Agents